Pityriasis rosea during COVID-19: Pathogenesis, diagnosis, and treatment.

Abstract

Dear Editor, the article by Martora F. et al. on a COVID-19 related atypical form of pityriasis rosea (PR)1 that was recently published in your journal prompted us to make some observations. We agree with the authors that SARS-CoV-2 infection may be a trigger of PR but, remarkably not directly. Indeed, it has been demonstrated that, SARS-CoV-2 infection may reactivate several latent viral infections such as human herpesvirus 6 (HHV-6) and HHV-7, and, therefore indirectly, induce the skin manifestations of PR.2-4 This article is protected by copyright. All rights reserved.